As of 2025-02-12, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is 287.91 USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.66 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is 781.5%.
The range of the Relative Valuation is 230.80 - 348.56 USD.
Range | Selected | |
Trailing P/E multiples | 19.5x - 27.9x | 23.9x |
Forward P/E multiples | 24.3x - 29.5x | 24.8x |
Fair Price | 230.80 - 348.56 | 287.91 |
Upside | 606.7% - 967.3% | 781.5% |
Date | P/E |
2025-02-07 | 2.83 |
2025-02-06 | 2.91 |
2025-02-05 | 2.91 |
2025-02-04 | 2.88 |
2025-02-03 | 2.84 |
2025-01-31 | 2.91 |
2025-01-30 | 2.92 |
2025-01-29 | 2.85 |
2025-01-28 | 2.84 |
2025-01-27 | 2.85 |
2025-01-24 | 2.91 |
2025-01-23 | 2.99 |
2025-01-22 | 2.88 |
2025-01-21 | 2.81 |
2025-01-17 | 2.74 |
2025-01-16 | 2.69 |
2025-01-15 | 2.81 |
2025-01-14 | 2.82 |
2025-01-13 | 2.90 |
2025-01-10 | 2.91 |
2025-01-08 | 3.04 |
2025-01-07 | 2.97 |
2025-01-06 | 2.84 |
2025-01-03 | 2.72 |
2025-01-02 | 2.69 |
2024-12-31 | 2.78 |
2024-12-30 | 2.79 |
2024-12-27 | 2.82 |
2024-12-26 | 2.91 |
2024-12-24 | 2.89 |
2024-12-23 | 2.99 |
2024-12-20 | 3.00 |
2024-12-19 | 3.03 |
2024-12-18 | 3.30 |
2024-12-17 | 3.55 |
2024-12-16 | 3.61 |
2024-12-13 | 3.30 |
2024-12-12 | 3.23 |
2024-12-11 | 3.67 |
2024-12-10 | 3.89 |
2024-12-09 | 4.11 |
2024-12-06 | 5.21 |
2024-12-05 | 4.99 |
2024-12-04 | 5.03 |
2024-12-03 | 4.98 |
2024-12-02 | 4.98 |
2024-11-29 | 5.02 |
2024-11-27 | 4.96 |
2024-11-26 | 5.00 |
2024-11-25 | 4.86 |